A Comprehensive Analysis of Two Prospective, Randomized, Multi-Center Trials Demonstrates the Ability of a Blood-Based Combinatorial Protein Biomarker Assay to Accurately Detect the Presence or Absence of Breast Cancer
Provista Diagnostics presented this poster at Miami Breast 2016 demonstrating a non-invasive, blood-based combinatorial proteomic biomarker assay (Videssa® Breast) that is to be used as an adjunct to standard-of-care imaging to detect the presence or absence of breast cancer.
Learn more by downloading the scientific poster
